Determination of Coenzyme Q10 Status in Blood Mononuclear Cells, Skeletal Muscle, and Plasma by HPLC with Di-Propoxy-Coenzyme Q10 as an Internal Standard
The DOI matches its Crossref record.
Abstract
Coenzyme Q10 (CoQ10), the predominant ubiquinone species in humans, functions as an electron carrier in the mitochondrial electron transport chain (ETC) and as an intracellular antioxidant (1). Although primary CoQ10 deficiency is rare, a profound deficiency in skeletal muscle CoQ10 has been reported in patients with multisystem mitochondrial encephalomyopathies (2)(3). Cardiovascular disease has been associated with a CoQ10 deficiency (4)(5), and it is becoming increasingly apparent that other groups of patients may become CoQ10 deficient, particularly individuals with ataxia (6) and some patients receiving statins (7). When assessing tissue CoQ10 status, we have found that the lack of a commercially available nonphysiologic internal standard (IS) is a major difficulty. Although naturally occurring ubiquinones have been used as ISs in this determination, they are not free from the influence of ubiquinones that might be present in human tissue as the result of dietary contamination (8) or synthesis by microorganisms (9)(10). There is a need, therefore, for an alternative IS that is not influenced by exogenous/endogenous ubiquinones. Di-ethoxy-CoQ10 has been suggested as a nonphysiologic IS to determine CoQ10 (11). In this study we evaluated this IS along with di-propoxy-CoQ10 for their suitability to determine tissue CoQ10. Reference intervals were established for the CoQ10 concentration of skeletal muscle, blood mononuclear cells (MNCs), and plasma. A patient with a suspected CoQ10 deficiency was subsequently identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics
Bhagavan, H. N., & Chopra, R. K. (2006) · Free Radical Research · doi:10.1080/10715760600617843 · Cited by 550
The in-depth evaluation of suspected mitochondrial disease
Haas, R. H., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darin, N., Wong, L.-J., Cohen, B. H., & Naviaux, R. K. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.11.018 · Cited by 365
Fibromyalgia: A Critical and Comprehensive Review
Borchers, A. T., & Gershwin, M. E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8509-4 · Cited by 275
Duncan, A. J., Bitner-Glindzicz, M., Meunier, B., Costello, H., Hargreaves, I. P., López, L. C., Hirano, M., Quinzii, C. M., Sadowski, M. I., Hardy, J., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.03.018 · Cited by 218
Self-citationGenetic bases and clinical manifestations of coenzyme Q10(CoQ10) deficiency
Desbats, M. A., Lunardi, G., Doimo, M., Trevisson, E., & Salviati, L. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9749-9 · Cited by 217
“It is possible to analyze also peripheral blood mononuclear cells (Duncan et al 2005).”
BackgroundGutierrez-Mariscal, F. M., Arenas-de Larriva, A. P., Limia-Perez, L., Romero-Cabrera, J. L., Yubero-Serrano, E. M., & López-Miranda, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217870 · Cited by 190
“Different studies have suggested that blood mononuclear cells may be a better tissue for monitoring endogenous CoQ10 than plasma, since they found a strong correlation between skeletal muscle and blood mononuclear cell CoQ10 status, but not with plasma in patients with no evidence of mitochondrial function-related dis…”
BackgroundDisorders of Human Coenzyme Q10 Metabolism: An Overview
Hargreaves, I., Heaton, R. A., & Mantle, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186695 · Cited by 182
“Typical reference ranges for skeletal muscle and fibroblasts CoQ10 status are 140–580 pmol/mg and 39–75 pmol/mg, respectively [63].”
BackgroundSelf-citationClinical applications of coenzyme Q₁₀
Garrido-Maraver, J. (2014) · Frontiers in Bioscience · doi:10.2741/4231 · Cited by 178
“CoQ10 content of BMCs was shown to correlate with skeletal muscle CoQ10 in un-supplemented subjects whereas the plasma concentrations did not (16).”
BackgroundCordero, M. D., De Miguel, M., Moreno Fernández, A. M., Carmona López, I. M., Garrido Maraver, J., Cotán, D., Gómez Izquierdo, L., Bonal, P., Campa, F., Bullon, P., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2918 · Cited by 165
“Interestingly, a positive correlation between the content of CoQ10 in BMCs and skeletal muscle [28,29] was demonstrated; therefore, CoQ10 deficiency and mitochondrial dysfunction can also be present in other cells and tissues in FM patients.”
The Roles of Coenzyme Q in Disease: Direct and Indirect Involvement in Cellular Functions
Pallotti, F., Bergamini, C., Lamperti, C., & Fato, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010128 · Cited by 109
Gold, W. A., Williamson, S. L., Kaur, S., Hargreaves, I. P., Land, J. M., Pelka, G. J., Tam, P. P. L., & Christodoulou, J. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.02.012 · Cited by 73
Self-citationSecondary Coenzyme Q 10 Deficiencies in Oxidative Phosphorylation (OXPHOS) and Non-OXPHOS Disorders
Yubero, D., Montero, R., Martín, M. A., Montoya, J., Ribes, A., Grazina, M., Trevisson, E., Rodriguez-Aguilera, J. C., Hargreaves, I. P., Salviati, L., et al. (2016) · Mitochondrion · doi:10.1016/j.mito.2016.06.007 · Cited by 72
Self-citationTarry-Adkins, J. L., Blackmore, H. L., Martin-Gronert, M. S., Fernandez-Twinn, D. S., McConnell, J. M., Hargreaves, I. P., Giussani, D. A., & Ozanne, S. E. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.09.004 · Cited by 47
Self-citation
Metadata
- Authors
- Duncan, A. J., Heales, S. J., Mills, K., Eaton, S., Land, J. M., & Hargreaves, I. P.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-12-01
- Volume
- 51
- Issue
- 12
- Pages
- 2380-2382
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2002532393
- Cited by
- 129
- References
- 0
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.